Safety, Ethics and Regulations

This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, intern...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Pham, Phuc Van (Editor), Rosemann, Achim (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2017.
Series:Stem Cells in Clinical Applications,
Subjects:
Online Access:Full Text via HEAL-Link
Table of Contents:
  • Part  I. Safety
  • Chapter 1: The safety of allogeneic stem cell transplantation
  • Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-related Chronic Neurodegenerative Diseases
  • Chapter 3: IClinical safety and applications of stem cell gene therapy
  • Chapter 4:  The safety of non-expanded multipotential stromal cell therapies
  • Part  II: Ethics and Regulations
  • Chapter 5: A Normative Case for the Patentability of Human Embryonic Stem Cell Technologies
  • Chapter 6. Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions
  • Chapter 7. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models
  • Chapter 8: Travelling cells – Harmonised European Regualtion and the BAMI stem cell trial
  • Chapter 9: Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines
  • Chapter 10: The regulation of clinical stem cell research in China
  • Chapter 11: Gov erning Stem Cell Therapies in India
  • Chapter 12: Patenting human embryonic stem cells in the European Union context: an updated analysis of a complex issue
  • Chapter 13: The regulatory situation for clinical stem cell research in China
  • Chapter 14: Contested Tissues: the donation of oocytes and embryos in the IVF-Stem Cell Interface in China
  • Chapter 15: Challenges to international stem cell clinical trials in countries with diverging regulations.